| Type : |
Journal |
| Internet-link : |
http://www.cjhp-online.ca/index.php/cjhp/article/view/1579/2386 |
|
| Forskerhold : |
Montreal - Faculté de pharmacie, Université de Montréal |
| Forfattere : |
Friciu M, Zaraa S, Leclair G. |
| Titel : |
Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions |
| Nummer : |
Can J Hosp Pharm ; 69, 4: 327-329. 2016 |
|
| Cotationvaleur : |
|
| Fysisk stabilitet : |
|
| Kemisk stabilitet : |
|
| Andre metoder : |
|
| Kommentarer : |
|
Lister
 Amlodipine besylate
|
 |
 |
 |
 |
30 mg
Norvasc® |
|
23-27°C |
 |
| 60 |
 |
|
|
|
|
 |
30 mg
® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
| 60 |
|
|
|
|
|
|
30 mg
Norvasc® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
30 mg
® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
| 90 |
|
|
|
|
 |
|
1 mg
Norvasc® |
|
23-27°C |
|
| 45 |
|
|
|
|
|
|
1 mg
® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
| 45 |
|
|
|
|
|
|
1 mg
Norvasc® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
1 mg
® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
| 90 |
|
|
|
|
|
